Novartis
NVS
NVS
1,011 hedge funds and large institutions have $20.7B invested in Novartis in 2018 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 373 increasing their positions, 377 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,011
Holders Change
+6
Holders Change %
+0.6%
% of All Funds
23.2%
Holding in Top 10
24
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.55%
New
76
Increased
373
Reduced
377
Closed
62
Calls
$86M
Puts
$45.7M
Net Calls
+$40.3M
Net Calls Change
+$20.6M
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$71.7M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$71M |
| 3 |
Millennium Management
New York
|
+$39.2M |
| 4 |
Two Sigma Investments
New York
|
+$36.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$35.6M |
